Ionis: Potentially A Great Time To Buy Ahead Of Q1 Earnings (Upgrade)

Core Insights - Ionis Pharmaceuticals is a developer of antisense oligonucleotide therapeutic drugs based in Carlsbad, California, and has compelling catalysts expected in 2025/26 [2] Company Overview - The company focuses on both novice and experienced biotech investors, providing insights on catalysts, buy and sell ratings, product sales forecasts, and integrated financial statements [2] Analyst Background - The analysis is led by a biotech consultant with over 5 years of experience covering biotech, healthcare, and pharma, having prepared detailed reports on over 1,000 companies [2]